Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84820 45822 14923 502
Operating income (EBITDA)11 21612 6164 9745 2185 5256 055
Operating profit (EBIT)9 0109 8334 0463 7354 1784 711
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 6463 1013 570
EPS ( $)3,013,721,621,491,972,30
Dividend per Share ( $)1,881,670,640,881,061,19
Yield4,32%3,84%1,47%2,02%2,44%2,74%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 6743 0865 8371 8031 167
Finance------
Operating income (EBITDA)11 21612 6164 9745 2185 5256 055
Leverage
(Debt/EBITDA)
0,77x0,77x0,62x1,12x0,33x0,19x
Capital Expenditure1 4921 7951 1451 0801 0881 250
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,5 $18,1 $19,2 $
Cash Flow per Share5,72 $5,85 $2,11 $3,18 $3,31 $3,59 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 65 396 M$ -
Entreprise Value (EV) 71 233 M$ 67 199 M$
Valuation 2014e 2015e
PER (Price / EPS) 29,3x 22,1x
Capitalization / Revenue 3,20x 2,95x
EV / Revenue 3,48x 3,03x
EV / EBITDA 13,7x 12,2x
Yield (DPS / Price) 2,02% 2,44%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,3% 18,9%
operating Leverage (Delta EBIT / Delta Sales) -1,21x 1,44x
Net Margin (Net Profit / Revenue) 12,9% 14,0%
ROA (Net Profit / Asset) 8,05% 7,80%
ROE (Net Profit / Equities) 12,9% 13,2%
Rate of Dividend 59,2% 53,8%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,28% 4,91%
Cash Flow / Sales (Taux d'autofinancement) 23,4% 22,5%
Capital Intensity (Assets / Sales) 1,61x 1,79x
Financial Leverage (Net Debt / EBITDA) 1,12x 0,33x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF